Antarctic network of lamp-calibrated multichannel radiometers for continuous ozone and uv radiation data

International audienceThree NILU-UV multichannel radiometers have been installed in 1999 at the Argentinian sites of Ushuaia (54S), Marambio (64S) and Belgrano-II (77S) in order to continuously monitor UV radiation, photosynthetically active radiation and total ozone. The measurements were established by INM, Spain in collaboration with FMI, Finland, DNA-IAA, Argentina and CADIC, Argentina to observe and characterize the spatial and temporal evolution of ozone and ultraviolet radiation in the Antarctic region. Special attention has been given to the quality control and quality assurance of the measurements under harsh climatological conditions. The ozone and UV time series of 2000?2006 were calibrated using a polynomial fit for lamp measurements performed every second week all year round. The gaps in these data are minimal, with almost no data missing, and the data products are available from http://www.polarvortex.org in near real time. The data products include the erythemally-weighted UV, UVB and UVA radiation, photosynthetically active radiation (PAR), total ozone (O3) and a cloud parameter (CLT). For UV data, dose rates as well as daily doses are available; from these the maximum measured UV indices (UVI), during 2000?2006, were 12.0, 9.7 and 8.1 at Ushuaia, Marambio and Belgrano-II, respectively

UV measurements at Marambio and Ushuaia during 2000–2010

Solar ultraviolet (UV) irradiances were measured with NILU-UV multichannel radiometers at Ushuaia (54°&thinsp;S) and Marambio (64°&thinsp;S) between 2000 and 2013. The measurements were part of the Antarctic NILU-UV network, which was started in cooperation between Spain, Argentina and Finland. The erythemally weighted UV irradiance time series of both stations were analysed for the first time. The quality assurance procedures included a travelling reference instrument to transfer the irradiance scale to the stations. The time series were homogenized and high quality measurements were available for the period 2000–2010. During this period UV indices of 11 or more were measured on 5 and 35 days at Marambio and Ushuaia, respectively. At Marambio, the peak daily maximum UV index of 12 and daily doses of around 7&thinsp;kJ&thinsp;m−2 were measured in November 2007. The highest UV daily doses at both stations were typically around 6&thinsp;kJ&thinsp;m−2 and occurred when the stations were inside the polar vortex, resulting in very low total ozone amount. At both stations, daily doses in late November could even exceed those in the summer. At Marambio, in some years, also daily doses in October can be as high as those during the summer. At Ushuaia, the peak daily maximum UV index of 13 was measured twice: in November 2003 and 2009. Also during those days, the station of Ushuaia was inside the polar vortex.</p

Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes

OBJECTIVE-Monocyte chemoattractant protein-1 (MCP-1), a chemokine binding to the CC chemokine receptor 2 (CCR2) and promoting monocyte infiltration, has been implicated in the pathogenesis of diabetic nephropathy. To assess the potential relevance of the MCP-1/CCR2 system in the pathogenesis of diabetic proteinuria, we studied in vitro if MCP-1 binding to the CCR2 receptor modulates nephrin expression in cultured podocytes. Moreover, we investigated in vivo if glomerular CCR2 expression is altered in kidney biopsies from patients with diabetic nephropathy and whether lack of MCP-1 affects proteinuria and expression of nephrin in experimental diabetes. RESEARCH DESIGN AND METHODS-Expression of nephrin was assessed in human podocytes exposed to rh-MCP-1 by immunofluorescence and real-time PCR. Glomerular CCR2 expression was studied in 10 kidney sections from patients with overt nephropathy and eight control subjects by immunohistochemistry. Both wild-type and MCP-1 knockout mice were made diabetic with streptozotocin. Ten weeks after the onset of diabetes, albuminuria and expression of nephrin, synaptopodin, and zonula occludens-1 were examined by immunofluorescence and immunoblotting. RESULTS-In human podocytes, MCP-1 binding to the CCR2 receptor induced a significant reduction in nephrin both mRNA and protein expression via a Rho-dependent mechanism. The MCP-1 receptor, CCR2, was overexpressed in the glomerular podocytes of patients with overt nephropathy. In experimental diabetes, MCP-1 was overexpressed within the glomeruli and the absence of MCP-1 reduced both albuminuria and downregulation of nephrin and synaptopodin. CONCLUSIONS-These findings suggest that the MCP-1/CCR2 system may be relevant in the pathogenesis of proteinuria in diabetes